Last reviewed · How we verify
Angle-closure glaucoma
Approved treatments
- Didroxan
- Keveyis
Keveyis works by inhibiting the enzyme carbonic anhydrase, which is involved in the production of aqueous humor in the eye. - Neptazane · Pfizer
- Diamox · Teva
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Angle-closure glaucoma patent landscape — cliff calendar, originator estates, attackable patents
- Angle-closure glaucoma treatment landscape brief
- Angle-closure glaucoma treatment updates RSS
Frequently asked questions about Angle-closure glaucoma
What drugs treat Angle-closure glaucoma?
Tracked treatments include Didroxan, Keveyis, Neptazane, Diamox.
What is the treatment for Angle-closure glaucoma?
Standard treatment for Angle-closure glaucoma includes Didroxan, Keveyis, Neptazane, Diamox. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Angle-closure glaucoma patent cliff · Angle-closure glaucoma CI report
- Treatment: Didroxan
- Treatment: Keveyis
- Treatment: Neptazane · Pfizer
- Treatment: Diamox · Teva
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing